METHAZOLAMIDE
Generic: METHAZOLAMIDE
Precision DoseManufacturer
ORALRoute
METHAZOLAMIDEActive Substance
2022-10-18Original Approval
METHAZOLAMIDE is FDA application ANDA215615, sponsored by TAGI. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
41 reports
2
DRUG INEFFECTIVE
40 reports
3
DIZZINESS
29 reports
4
OFF LABEL USE
29 reports
5
DYSPNOEA
28 reports
6
HEADACHE
28 reports
7
BLOOD PRESSURE INCREASED
22 reports
8
ASTHENIA
21 reports
9
ANXIETY
20 reports
10
DEATH
20 reports